$137,304,316

Funds the Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases at UMass Medical School, an ongoing research initiative that began in 2018.

Supports development of rapid diagnostic and monitoring technologies for critical cardiovascular and respiratory conditions, advancing clinical care delivery beyond traditional hospital settings.

Drives demand for point-of-care device manufacturers, diagnostic reagent suppliers, and biomedical instrumentation vendors serving academic medical centers.

Point-of-care diagnostics are a strategic priority; U.S. investment in this research supports domestic innovation against growing Chinese competition in portable medical devices.